Optic neuropathy secondary to perhexiline and amiodarone.


Journal

BMJ case reports
ISSN: 1757-790X
Titre abrégé: BMJ Case Rep
Pays: England
ID NLM: 101526291

Informations de publication

Date de publication:
27 Jan 2021
Historique:
entrez: 28 1 2021
pubmed: 29 1 2021
medline: 24 2 2021
Statut: epublish

Résumé

Bilateral optic disc swelling is an important clinical sign for potentially life-threatening and sight-threatening conditions, with the most common being raised intracranial pressure and pseudopapillitis. Perhexiline-related and amiodarone-related optic disc swellings are diagnoses of exclusion. This report describes the diagnosis of a man with perhexiline-induced and amiodarone-induced optic neuropathy after extensive investigation consisting of full ophthalmic examination, biochemical screen, temporal artery biopsy, CT, MRI, positron emission tomography and lumbar puncture. There was partial to complete resolution of optic neuropathy following cessation of the causative medication. We postulate that the underlying mechanism of perhexiline toxicity could be mitochondrial dysfunction related. Our case demonstrates that patients treated with perhexiline and amiodarone should be monitored closely for ocular side effects.

Identifiants

pubmed: 33504523
pii: 14/1/e237727
doi: 10.1136/bcr-2020-237727
pmc: PMC7843302
pii:
doi:

Substances chimiques

Vasodilator Agents 0
Perhexiline KU65374X44
Amiodarone N3RQ532IUT

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© BMJ Publishing Group Limited 2021. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Neurology. 2006 Nov 14;67(9):1690-1
pubmed: 17101909
Cardiology. 1996 Jan-Feb;87(1):90
pubmed: 8631054
Hepatology. 1994 Apr;19(4):948-61
pubmed: 8138270
J Pharmacol Exp Ther. 1990 Dec;255(3):1371-6
pubmed: 2124623
Cardiovasc Drug Rev. 2007 Spring;25(1):76-97
pubmed: 17445089
J Neurol Neurosurg Psychiatry. 1987 May;50(5):651
pubmed: 3585402
Br J Ophthalmol. 1984 Aug;68(8):553-60
pubmed: 6743625
Aust N Z J Med. 1995 Apr;25(2):111-3
pubmed: 7605290
J Clin Neuroophthalmol. 1988 Dec;8(4):231-7
pubmed: 2977138
Neuroophthalmology. 2016 Nov 18;41(2):55-58
pubmed: 28348626
Crit Care Med. 1985 Aug;13(8):688-9
pubmed: 4017601
Middle East Afr J Ophthalmol. 2008 Apr;15(2):81-6
pubmed: 21346843
Am J Ophthalmol. 1993 Dec 15;116(6):776-7
pubmed: 8250090
Br Med J. 1978 Feb 25;1(6111):509
pubmed: 626862

Auteurs

Yiran Tan (Y)

South Australian Institute of Ophthalmology, Royal Adelaide Hospital, Adelaide, South Australia, Australia ian.tan1100@gmail.com.
Discipline of Ophthalmology and Visual Sciences, The University of Adelaide, Adelaide, South Australia, Australia.

Paul Sia (P)

South Australian Institute of Ophthalmology, Royal Adelaide Hospital, Adelaide, South Australia, Australia.

Sumu Simon (S)

South Australian Institute of Ophthalmology, Royal Adelaide Hospital, Adelaide, South Australia, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH